Engineered T cells and their therapeutic applications in autoimmune diseases

被引:18
作者
Bao, Lei [1 ]
Bo, Xiao-Chen [1 ]
Cao, Huai-Wen [1 ]
Qian, Chen [1 ]
Wang, Zeng [1 ]
Li, Bin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Dept Immunol & Microbiol, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Chimeric antigen receptor T cells; Cell immunotherapy; Autoimmune diseases; SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELL; RHEUMATOID-ARTHRITIS; PEMPHIGUS-VULGARIS; CD19; CAR; CLINICAL DEVELOPMENT; MICROSCOPIC COLITIS; GENE-TRANSFER; IN-VITRO; ANTIGEN;
D O I
10.24272/j.issn.2095-8137.2021.363
中图分类号
Q95 [动物学];
学科分类号
071002 ;
摘要
Chimeric antigen receptor T cells (CAR-T cells) are engineered recombinant T cells, which were initially used to treat hematopoietic malignancies and are now widely used in the treatment of various diseases. Considering their intrinsic targeting efficiency, CAR-T cells show considerable potential in the treatment of autoimmune diseases. Furthermore, regulatory T cells (Treg), a subset of CD4 T cells exhibiting immunosuppressive functions, have attracted increasing attention regarding CAR-Treg cell production. In this review, we report on recent developments in preclinical and clinical studies on CAR-T cells in autoimmune diseases and provide an outlook on opportunities and challenges of CAR-T application in such diseases.
引用
收藏
页码:150 / 165
页数:16
相关论文
共 146 条
  • [1] Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma
    Abramson, Jeremy S.
    [J]. TRANSFUSION MEDICINE REVIEWS, 2020, 34 (01) : 29 - 33
  • [2] Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy
    Acharya, Utkarsh H.
    Dhawale, Tejaswini
    Yun, Seongseok
    Jacobson, Caron A.
    Chavez, Julio C.
    Ramos, Jorge D.
    Appelbaum, Jacob
    Maloney, David G.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (03) : 195 - 205
  • [3] Adams SM, 2013, AM FAM PHYSICIAN, V87, P699
  • [4] AUTOANTIBODIES AGAINST A NOVEL EPITHELIAL CADHERIN IN PEMPHIGUS-VULGARIS, A DISEASE OF CELL-ADHESION
    AMAGAI, M
    KLAUSKOVTUN, V
    STANLEY, JR
    [J]. CELL, 1991, 67 (05) : 869 - 877
  • [5] Use of autoantigen-knockout mice in developing an active disease model for pemphigus
    Amagai, M
    Tsunoda, K
    Suzuki, H
    Nishifuji, K
    Koyasu, S
    Nishikawa, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (05) : 625 - 631
  • [6] Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
    Atarashi, Koji
    Tanoue, Takeshi
    Oshima, Kenshiro
    Suda, Wataru
    Nagano, Yuji
    Nishikawa, Hiroyoshi
    Fukuda, Shinji
    Saito, Takuro
    Narushima, Seiko
    Hase, Koji
    Kim, Sangwan
    Fritz, Joelle V.
    Wilmes, Paul
    Ueha, Satoshi
    Matsushima, Kouji
    Ohno, Hiroshi
    Olle, Bernat
    Sakaguchi, Shimon
    Taniguchi, Tadatsugu
    Morita, Hidetoshi
    Hattori, Masahira
    Honda, Kenya
    [J]. NATURE, 2013, 500 (7461) : 232 - +
  • [7] Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
    Bai, Yun
    Kan, Shifeng
    Zhou, Shixin
    Wang, Yuting
    Xu, Jun
    Cooke, John P.
    Wen, Jinhua
    Deng, Hongkui
    [J]. CELL DISCOVERY, 2015, 1
  • [8] Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells
    Beavis, Paul A.
    Gregory, Bernard
    Green, Patricia
    Cribbs, Adam P.
    Kennedy, Alan
    Amjadi, Parisa
    Palfreeman, Andrew C.
    Feldmann, Marc
    Brennan, Fionula M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (40) : 16717 - 16722
  • [9] Characterization of Relapsing-Remitting and Chronic Forms of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice
    Berard, Jennifer L.
    Wolak, Kevin
    Fournier, Sylvie
    David, Samuel
    [J]. GLIA, 2010, 58 (04) : 434 - 445
  • [10] Bernstroem KE, 2016, CYTOTHERAPY, V18, pS59